Enlivex Therapeutics Ltd (ENLV)

Tel Aviv
Currency in ILS
410
+4(+0.98%)
Delayed Data·
ENLV Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ENLV is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
408422
52 wk Range
309629
Key Statistics
Edit
Bid/Ask
407.00 / 415.00
Prev. Close
406
Open
408
Day's Range
408-422
52 wk Range
309-629
Volume
17.66K
Average Volume (3m)
24.18K
1-Year Change
-17.35%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ENLV Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Enlivex Therapeutics Ltd News & Analysis

Show more

Enlivex Therapeutics Ltd Company Profile

Enlivex Therapeutics Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. Its product pipeline is the Allocetra (ENX-CL-02-002), which is in phase II clinical trial for the treatment of organ dysfunction and failure caused by sepsis; and Allocetra (ENX-CL-05-001), which is in phase I/II clinical trial to treat moderate knee osteoarthritis. The company also develops 0189-22-KMC, which is in phase I/II clinical trial to treat end-stage knee osteoarthritis; 0006-24-KMC, which is in phase I/II clinical trial for the treatment of Basal thumb osteoarthritis; and ENX-CL-06-001 to treat Psoriatic arthritis and is in phase I/II clinical trial. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Ness Ziona, Israel.

Compare ENLV to Peers and Sector

Metrics to compare
ENLV
Peers
Sector
Relationship
P/E Ratio
−1.8x−3.7x−0.5x
PEG Ratio
−0.04−0.030.00
Price/Book
1.3x2.4x2.6x
Price / LTM Sales
-7.2x3.0x
Upside (Analyst Target)
-620.3%52.5%
Fair Value Upside
Unlock17.7%8.7%Unlock

Earnings

Latest Release
Mar 31, 2025
EPS / Forecast
-0.23 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ENLV Income Statement

FAQ

What Is the Enlivex (ENLV) Stock Price Today?

The Enlivex stock price today is 410.00

What Stock Exchange Does Enlivex Trade On?

Enlivex is listed and trades on the Tel Aviv Stock Exchange stock exchange.

What Is the Stock Symbol for Enlivex?

The stock symbol for Enlivex is "ENLV."

What Is the Enlivex Market Cap?

As of today, Enlivex market cap is 93.97M.

What Is Enlivex's Earnings Per Share (TTM)?

The Enlivex EPS (TTM) is -0.66.

From a Technical Analysis Perspective, Is ENLV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Enlivex Stock Split?

Enlivex has split 0 times.

How Many Employees Does Enlivex Have?

Enlivex has 0 employees.

What is the current trading status of Enlivex (ENLV)?

As of 24 Jun 2025, Enlivex (ENLV) is trading at a price of 410.00, with a previous close of 406.00. The stock has fluctuated within a day range of 408.00 to 422.00, while its 52-week range spans from 309.00 to 629.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.